Introduction
In all vertebrate gastrula stage embryos analysed to date the homeobox gene goosecoid (gsc) marks the equivalent of the so-called Spemann organizer (De Robertis et al., 1992) . This tissue, which in amphibians resides in the dorsal lip of the blastopore, is able to induce a complete secondary body axis when grafted onto the ventral side of a recipient embryo (Spemann and Mangold, 1924) . A role in dorsal mesodermal patterning is suggested because ectopic goosecoid is induced by treatment of Xenopus and mouse gastrula stage embryos with the mesoderm inducing growth factor activin Blumberg et al., 1991; Cho et al., 1991) .
When gsc mRNA is injected into ventral blastomeres of a 16-cell embryo of Xenopus and ventral marginal zone explants are cultured in vitro, dierentiation of blood is suppressed (Niehrs et al., 1993 (Niehrs et al., , 1994 . Increasing the dose of injected gsc mRNA induces ectopic pronephros, muscle, notochord, and neural tissue in similar explant cultures (Niehrs et al., 1994) .
The TGFb-like signaling molecule activin has also been studied as an erythrocyte dierentiation factor, based on its ability to induce red blood cell maturation (Eto et al., 1987; Yu et al., 1987) . In order to investigate the suppression of erythroid dierentiation by goosecoid further, we ectopically expressed gsc in an erythroblastic cell line. We found that goosecoid severely compromises terminal dierentiation of these cells in response to activin. We explored the mechanism of this eect and identi®ed the oncogene PU.1 (also known as a Spi-1) as a GOOSECOID (GSC) interacting molecule.
Many transcription factors are thought to play a role in erythropoiesis, such as GATA-1 (Kulessa et al., 1995; Tsai et al., 1991) , GATA-2 (Tsai et al., 1994) , PU.1 (Hromas et al., 1993; Schuetze et al., 1992 Schuetze et al., , 1993 and SCL (Aplan et al., 1992; Begley et al., 1989; Shivdasani and Orkin, 1996) . Among these, the role of PU.1 in erythropoiesis is still controversial.
The retinoblastoma tumor suppressor gene (Rb) has been thought to be involved in the process of erythrocyte dierentiation as well. We found that a *40 kDa protein associated with Rb decreased speci®cally in response to activin treatment. We show that this protein band corresponds to PU.1, and that GSC and Rb compete in their binding to the Nterminal portion of PU.1 in vitro. In addition, we show that expression of the N-terminal portion of PU.1 rescued activin-induced dierentiation, which was suppressed by GSC.
Results

Ectopic expression of goosecoid (gsc) in the erythroblast cell line F5-5 blocks activin-induced dierentiation into erythrocytes
To examine the eects of gsc expression on erythroid dierentiation, we stably transfected a gsc expression construct, which drives expression from the CMV promoter, into the erythroblast cell line F5-5. This line dierentiates into erythrocytes in response to activin (Ikawa et al., 1976; Eto et al., 1987) . Untransfected or vector-transfected F5-5 cells, treated or untreated with activin, did not express gsc mRNA (data not shown). In order to test if the ability to respond to activin induction was altered in gsc transfected F5-5 cells, we randomly picked four independent clones (gsc74-1 ± 4) and determined the percentage of hemoglobin-positive cells following activin treatment. As shown in Figure  1a , approximately 50 per cent of vector transfected cells expressed hemoglobin, while this number was reduced dramatically in gsc expressing clones. Next, we determined if this reduction in dierentiation potential was due to reduced cell proliferation in gsc expressing clones. We analysed one clone (gsc74-3) in detail which displayed particularly reduced hemoglobin expression over a wide range of activin concentrations ( Figure  1b) . Cell numbers after 6 days of stimulation with activin were always signi®cantly higher in gsc74-3 cultures compared to vector transfectants (Figure 1c) , demonstrating that expression of GSC did not inhibit cell growth.
The retinoblastoma protein (Rb) is involved in the dierentiation of F5-5 erythroblasts
In Rb-de®cient mice (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992) erythroid precursors show defects in terminal dierentiation. We therefore asked if Rb is involved in activin-induced dierentiation of F5-5 cells. To investigate this question, we stably introduced Rb into F5-5 cells in either sense or antisense orientation and assayed the capacity of transfected cultures to dierentiate. As shown in Figure 2a , sense Rb led to a higher percentage of hemoglobin positive cells following activin treatment, while antisense Rb signi®cantly inhibited the differentiation of this cell line. These eects were seen over a wide range of activin concentrations (Figure 2a ). This experiment strongly suggests that Rb plays a role in the activin-induced dierentiation of F5-5 cells.
As interaction of Rb with other proteins has been demonstrated in a number of contexts (Chellappan et al., 1991; Dowdy et al., 1993; Gu et al., 1993; Hagemeier et al., 1993; Whyte et al., 1988) , we hypothesized that a speci®c interaction might occur in F5-5 cultures upon activin treatment. F5-5 cells were cultured with or without activin and immunoprecipitated with rabbit anti-Rb antibodies or rabbit anti-CDK4 antibodies as control. As shown in Figure 2b , a protein of 38 ± 42 kDa co-precipitated with Rb in the absence of activin, and this band was signi®cantly decreased following activin treatment. On the other hand, factors co-precipitating with CDK4 did not appear dierent in activin treated and untreated cultures (Figure 2b ). Immunoprecipitates with anti-Rb antibodies were subjected to re-immunoprecipitation with anti-PU.1 antibodies as described in Materials and methods. We could detect at least two bands of 38 ± 42 kDa in the absence of activin with anti-PU.1 antibodies. In the presence of activin, however, these bands almost disappeared (Figure 2c ).
Identi®cation of the GSC binding protein as the product of the oncogene PU.1
To test whether GSC inhibits erythrocyte differentiation by binding to a protein required for this process, GSC binding molecules were analysed in F5-5 cells in the presence or absence of activin (Figure 3a) . Lysates from metabolically labeled F5-5 cells were subjected to anity chromatography on beads with immobilized GST-GSC fusion protein. This experiment identi®ed a protein of 38 ± 42 kDa which was markedly decreased in cells treated with activin (arrow in Figure 3a) .
Among the molecules that bind to Rb and are presumably involved in erythroid dierentiation is the Figure 1 Expression of gsc suppressed erythroid dierentiation but did not inhibit cell growth. (a) Suppression of erythroid dierentiation in gsc expressing F5-5 cell clones. Vector transfected (Vector) and four individual clones (gsc74-1 ± 4) were cultured in the presence or absence of activin (100 ng/ml) for 6 days at 1610 3 cells/100 ml/well in a 96-well microplate. After 6 days, cultures were stained with dianisidine to detect hemoglobin positive cells (Eto et al., 1987) ets family protein PU.1 (Klemsz et al., 1990; Hagemeier et al., 1993) with a molecular weight between 36 and 46 kDa (Schuetze et al., 1992; Scott et al., 1994) . To investigate a possible interaction of PU.1 and GSC, lysates from metabolically labeled F5-5 cells from both untreated and activin stimulated cultures were subjected to sequential anity chromatography on GST-GSC beads, followed by immunoprecipitation of eluted material with an anti-PU.1 antibody. Figure 3b shows that a protein band of 38 ± 42 kDa was drastically decreased in cultures treated with activin. This was also con®rmed by Western blot (Figure 3c ). To test the speci®city of this interaction, we analysed if other members of the ets family could also bind to GSC. PU.1, Fli-1 (BenDavid et al., 1991) and Ets-2 (Watson et al., 1988) were in vitro translated in the presence of [ S-labeled proteins were pulled down with GST-GSC-beads. Figure 4a shows that GSC beads bound PU.1 speci®cally but did not bind to Ets-2 or Fli-1.
To identify relevant interaction sites,
35
S-labeled GSC was in vitro translated and pulled down either with a GST fusion protein containing the N-terminal portion of PU.1 (amino acids 1 ± 132) or with a His-tag fusion protein containing the C-terminal half (amino acids 132 ± 272). As shown in Figure 4b , GSC exclusively bound to the N-terminal portion of PU.1. Figure 4b shows that 35 S-labeled GSC did not bind to SCL-beads.
Competition of GSC and Rb for PU.1 binding
In order to analyse if GSC and Rb interact at the protein level, in vitro translated 35 S-labeled Rb was subjected to a pull-down assay with GST-GSC. Figure  5a shows that no binding of these two proteins was detectable in this experiment. To determine if GSC blocks the interaction between PU.1 and Rb, 35 Slabeled Rb and GSC proteins were mixed and incubated with beads loaded with the N-terminal portion of PU.1 fused to GST (Figure 5b ). In the absence of GSC, Rb bound speci®cally to PU.1-Nterminal beads. At a one to one molar ratio, both Rb and GSC bound to PU.1-N-terminal beads. By increasing the GSC to Rb ratio to nine to one, binding of Rb to PU.1 was dramatically reduced. Thus GSC appeared to compete with Rb in its binding to the N-terminal portion of PU.1. Our data suggest that GSC and Rb share common or overlapping binding sites in the amino terminal region of PU.1 in agreement with a previous report (Hagemeier et al., 1993) . The N-terminal part of PU.1 rescues activin-induced erythroid dierentiation in GSC-expressing cells If GSC suppressed erythroid dierentiation of F5-5 cells by inhibiting the interaction between PU.1 and Rb, activin responsiveness should be recovered by forced expression of PU.1 or the N-terminal part of PU.1 (N-PU.1). We therefore stably introduced PU.1 or the N-terminal part of the gene into clone F5-5gsc74-3. The dierentiation capacity of gsc and PU.1 or gsc and N-PU.1 double transfectants (F5-5gsc74-3/ PU.1 and F5-5gsc74-3/N-PU.1) was compared with that of control cells (F5-5gsc74-3/pCEP4). As depicted in Table 1 , introduction of either the N-terminal part of PU.1 or the intact PU.1 gene into the transfected F5-5gsc74-3 line rescued the capacity of these cells to produce hemoglobin in response to activin ( Table 1 ). The N-terminal fragment of PU.1 was speci®cally detected in a pull-down assay with GST-GSC in the N-PU.1 line but not in vector transfected cells ( Figure  6a ).
To show that rescue was not caused by altered GSC concentrations in the double-transfected cultures, protein levels were assessed by immunoprecipitation (Figure 6b ). Polyclonal antibodies raised in guinea-pigs recognized a protein of apparent MW 33 kDa both in in vitro translation reactions and in the gsc expressing F5-5 cell clone gsc74-3 (data not shown). Figure 6b shows that the level of GSC was identical in vector and N-PU.1 transfected gsc74-3.
Detection of PU.1-GSC complexes in vivo
To investigate if the PU.1-GSC complex exists in vivo, lysates of the gsc expressing F5-5 clone gsc74-3 were immunoprecipitated with anti-PU.1 antibodies, precipitates were resolved, and pulled down with PU.1-Nterminal beads. An additional band of about 33 kDa was found in gsc74-3 cells compared to vector transfected cells (pcDNA3; Figure 7a ).
In the reverse experiment, gsc74-3/N-PU.1 and gsc74-3/pCEP4 cell lysates were immunoprecipitated with anti-GSC antibodies and resolved proteins were re-immunoprecipitated with anti-N-terminal peptides of PU.1 antibodies. A band of approximately 25 kDa was detected only from gsc74-3/N-PU.1 cells ( Figure  7b ). These experiments suggest that GSC-PU.1 complexes exist in vivo.
It is possible that GSC could replace Rb in complexes with PU.1. If so, reduced levels of Rb should be observed following immunoprecipitation with anti-PU.1 antibodies. Figure 8 shows that this is indeed the case. The ratio of Rb : PU.1, expressed as the ratio of radioactivity in each band following SDS ± PAGE analysis of immunoprecipitates, was reduced in GSC expressing cells (gsc74-3) compared to control F5-5 cells, which were transfected with the empty vector pcDNA3. This value was unchanged upon additional transfection of a second expression vector, pCEP4, but was dramatically increased when PU.1 was expressed (gsc74-3/PU.1). The value was not only rescued but indicated a more than doubled relative concentration of Rb. We estimate that the Rb/PU.1 ratio in radioactivity (PSL: Photo Stimulated Luminescence) is 4 : 1 from immunoprecipitation with anti-Rb antibodies (data not shown). With PU.1 in excess in gsc74- When erythrocytes matured, PU.1 molecules became smaller in size in response to activin Levels of PU.1 were observed in F5-5 and its derivative cells in response to activin. PU.1 was down-regulated, when F5-5pcDNA3 or F5-5gsc74-3/PU.1 cells successively matured in response to activin (Figure 9a,c) . In contrast, GSC expressing F5-5gsc74-3 or F5-5gsc74-3/ pCEP4 cells had constant level of *40 kDa PU.1 either in the presence or absence of activin (Figure 9b and data not shown).
Our experiments suggest that GSC suppressed the down-regulation of PU.1, in part, by forming GSC- 35 S-Rb was precleared with GST-control beads and divided into three batches. One was incubated with GST-PU.1-N-terminal beads in the absence of GSC. In the second and third reaction GSC and Rb were added at a 1 : 1 and 9 : 1 ratio, respectively. Bound proteins were resolved by 8 ± 16% SDS ± PAGE and analysed by a BAS-2000 Bioimager PU.1 complex, which results in the failure of cells to dierentiate into red cells upon activin stimulation.
Discussion
Goosecoid (gsc) was isolated from the dorsal lip of Xenopus laevis gastrula stage embryos as a protein that mimics Spemann's organizer activity Blumberg et al., 1991; Niehrs et al., 1993) . Here, we tried to ask two things by expressing gsc gene in erythroblastic cells. One is to get information on the mechanism of gsc function in early embryogenesis. Although GSC is not expressed in the later differentiation stage of erythrocytes, it is expected to be expressed in early blood cell progenitors. Injection of lower doses of gsc mRNA in Xenopus embryo could induce blood cell formation and that of higher doses inhibited the blood formation (Niehrs et al., 1994) . The other purpose is to ask the relation between cell cycle controlling molecules such as Rb and the molecules involved in cell lineage commitment. By ectopically expressing goosecoid in erythroblastic cell line, we tried to clarify the cooperative interaction between cell cycle controlling molecules and molecules involved in lineage commitment in erythroid cell development.
We expressed GSC in the erythroblastic cell line, F5-5 (Ikawa et al., 1976) , a line that dierentiates into hemoglobin producing cells in response to activin (Eto et al., 1987) . Although F5-5 cells do not express gsc mRNA, even following activin treatment (data not shown), forced expression of gsc via stable transfection inhibited activin-induced dierentiation.
Rb7/7 mice and our F5-5 cells transfected with antisense Rb construct show defects in erythroblast dierentiation (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992;  Figure 2a) . Immunoprecipitation of F5-5 lysates with anti-Rb antibodies coprecipitated a *40 kDa protein, whose levels decreased in response to activin and it was re-immunoprecipitated with anti-PU.1 antibodies (Figure 2b,c) . Immunoprecipitation with anti-PU.1 antibodies of lysates from untreated and activin-treated F5-5 cells showed activin-mediated down-regulation of major species of *40 kDa, and upregulation of minor protein species of 30 ± 38 kDa ( Figure 9) . A protein similar in size to PU.1 binds GSC and is down-regulated in cells treated with activin ( Figure 3a) . We proved that this protein is PU.1 by immunoprecipitation and Western blot of GSC bound molecules using anti-PU.1 antibodies (Figure 3b,c) .
An important issue addressed here is whether GSC-PU.1 complexes exist in vivo. We detected GSC proteins by pull-down assay with beads coupled to the PU.1-N-terminal domain from anti-PU.1 immunoprecipitates (Figure 7a) . Furthermore, we detected the F5-5 cells and those transfected with various genes (1610 4 /ml) were cultured either in the presence or absence of activin as described in the legend of Figure 1 . After 6 days, the percentage of dianisidine positive cells was estimated by counting. Results were expressed as the mean+s.e. of four wells. Asterisk (*) indicates that there are signi®cant dierences between these groups (P50.05, Student's ttest).
N-terminal portion of PU.1 in immunoprecipitates with anti-GSC antibodies in gsc and N-PU.1 double transfectants (gsc74-3/N-PU.1 cells; Figure 7b ). These data suggest that such complexes exist in vivo.
Several lines of evidence indicate that PU.1 plays an important role in embryonic blood formation. One strain of PU.1 knock out mice shows defects in erythroid maturation (Scott et al., 1994) . Another PU.1 de®cient mouse strain exhibits no apparent defects in erythrocyte development but are de®cient in macrophages, neutrophils, B cells, and T cells compared to wild-type mice (McKercher et al., 1996; Scott et al., 1997) . In both strains, however, the Nterminal half of the PU.1 gene is intact in the targeted genome, and in neither case has it been determined whether the N-terminal peptide is expressed. We show ( Table 1) that such a truncated protein is functional in vivo.
Transgenic mice expressing PU.1 under the control of a SFFV LTR develop a multistep erythroleukemia at rate of 50% (Moreau-Gachelin et al., 1996) . The rest become anemic and their hematopoietic tissue is invaded with proerythroblasts highly expressing PU.1. These proerythroblasts are partially blocked in dierentiation, suggesting that PU.1 plays a role in erythroblast self renewal (Schuetze et al., 1993; Moreau-Gachelin et al., 1996) . Therefore, although PU.1 is expressed in the course of erythroid differentiation, its overexpression appears to block differentiation. It is reported that overexpression of PU.1 also inhibits growth and dierentiation of murine erythroleukemia cells (Rao et al., 1997; Yamada et al., 1997) . Here, we showed that overexpression of PU.1 suppressed the dierentiation of F5-5 cells, while it rescued the dierentiation which was suppressed by GSC (Table 1) . We propose that equimolar levels of PU.1 with GSC are necessary to inactivate GSC and Lysates from gsc74-3/pCEP4 and gsc74-3/N-PU.1 were immunoprecipitated with anti-GSC antibodies. Resolved proteins were re-immunoprecipitated with anti-N-terminal peptides of PU.1 antibodies. Bound or precipitated proteins were separated on 8 ± 16% SDS ± PAGE and analysed by a BAS-2000 Bioimager restore the ability of erythrocytes to dierentiate. We hypothesize that PU.1 is necessary at the beginning of erythrocyte dierentiation but that its down-regulation following activin stimulation is necessary for differentiation to proceed (Rao et al., 1997) . Interestingly, when gsc-PU.1 double transfectants (F5-5gsc74-3/PU.1 cells) were stimulated with activin, a part of PU.1 remained unchanged and the rest of PU.1 became smaller (Figure 9c) . It was expected that GSC-bound PU.1 was protected from down-regulation and other PU.1 which was free from GSC was down-regulated upon stimulation with activin. When F5-5gsc74-3 cells were stimulated with activin, almost all PU.1 molecules remained unchanged (Figure 9b ). This fact suggests that GSC protects Rb-bound PU.1 as well as GSCbound PU.1 from down-regulation. We con®rmed that Rb-bound PU.1 remained unchanged after the stimulation with activin in F5-5gsc74-3 (data not shown). In summary, GSC inhibits not only PU.1's binding to Rb, but also the down-regulation of PU.1 by in¯uencing the Rb-PU.1 interaction with unknown mechanism. The triggering of down-regulation of PU.1 probably depends on the molar ratio among PU.1, Rb and GSC, because introduction of excess amounts of PU.1 can rescue the erythrocyte dierentiation suppressed by GSC.
Also expression of the N-terminal domain of PU.1 restores the responsiveness of gsc74-3 cells to activin ( Figure 6 , Table 1, Exp. 2). It is predicted that the Nterminal domain of PU.1 does not eciently inhibit the binding of native PU.1 to Rb due to the lower binding anity of the fragment compared to the native protein.
It has been reported that the N-terminal 75 residues of PU.1 bind Rb weakly, but sequences between residues 75 and 182 are required for full Rb-binding (Hagemeier, et al., 1993) . In contrast, binding of PU.1 to GSC depends only on the N-terminal portion of PU.1 (Figure 4) . Therefore, the N-terminal portion of PU.1 may inhibit the GSC-PU.1 interaction without signi®cantly interfering with that of Rb and PU.1. It is F5-5gsc74-3 , size of PU.1 remained unchanged and dierentiation was suppressed. (c) In F5-5gsc74-3/PU.1, both smaller species of PU.1 and regular size PU.1 existed in the presence of activin and dierentiating ability was recovered. In the schema, the regular size PU.1 is shown as rectangles and smaller species of PU.1 is shown as round forms unlikely that recovery from inhibition by forced expression of PU.1 is mediated by direct induction of target genes, because the N-terminal portion of PU.1, a domain containing two activation domains (Klemsz and Maki, 1997) , eectively relieves that inhibition.
If GSC competes with Rb in binding to PU.1 in vivo, the level of Rb would decrease in anti-PU.1 immunoprecipitates in gsc-expressing cells compared to that of control cells. We observed such a decline in Rb and that was reversed in gsc/PU.1 double transfectants (Figure 8 ). This is not a simple decline of the Rb-PU.1 complex, because GSC does not allow the down-regulation of PU.1 which always accompany successive dierentiation of erythrocytes (Figure 9 and our unpublished results). Although we have discussed erythrocyte dierentiation in terms of Rb and PU.1, we cannot exclude the possibility that GSC inhibits the binding of Rb to other factor which positively regulates erythrocyte maturation. It is also possible that GSC inhibit the binding of PU.1 to other protein which is necessary for terminal dierentiation of erythrocytes. The dynamic interactions among PU.1, Rb, and other factors remain to be solved. Mechanism of stabilization of PU.1 by GSC also remains to be answered.
To further characterize the mechanism of inhibition of blood formation in early embryogenesis, it is necessary to examine the interaction among PU.1, Rb, SCL, and GSC. Taken together, our results indicate that GSC can block activin-induced erythroid dierentiation by binding to a speci®c ets protein, PU.1. The interaction of GSC with PU.1 may shed light not only on one aspect of dorso-ventral patterning during embryogenesis, but also on the cooperative work among bHLH family, Rb family, and homeodomain-containing family during differentiation.
Materials and methods
Cell lines
The F5-5 cell line was originally established by Dr Yoji Ikawa (Tokyo Medical and Dental University, School of Medicine; Ikawa et al., 1976 ). An activin high responder subclone was supplied by Dr Yuzuru Eto (Central Research Laboratories, Ajinomoto Co., Inc.; Eto et al., 1987) . This subclone was grown in F12 (F12 Nutrient Mixture, Gibco BRL) supplemented with 8% fetal calf serum.
Antibodies
Antibodies against mouse retinoblastoma protein (Rb) were raised by immunizing rabbits (JW) with the peptide CFETERTPRKNNPDEEANVVT. This peptide corresponds to amino acids 344 ± 363 (Bernards et al., 1989) and carries a C at the amino terminus which was coupled to keyhole limpet hemocyanin. Antibodies against mouse PU.1 protein were raised by immunizing rabbits (JW) with the peptide CTYQFSGEVLGRGGLAERRLPPH (amino acids 251 ± 272 of PU.1 (Klemsz et al., 1990) as described above. Antibodies against N-terminal peptides of PU.1 were raised by immunizing rabbits.
Antibodies against mouse CDK4 were raised by immunizing rabbits (JW) with the peptide TFNPHKRISAFRALQH-SYLH (amino acids 277 ± 296 of CDK4 cDNA (Matsushime et al., 1992) ) coupled to keyhole limpet hemocyanin. All antibodies were anity puri®ed using immunizing peptide.
Anti-GSC antisera were obtained by immunizing guinea-pigs (Hartley) with GST (glutathione S-transferase)-GSC-agarose beads. Anti-GST-GSC antisera were absorbed twice with equal volumes of GST-agarose beads. Anti-GSC antisera thus prepared cannot recognize a denatured form of antigen. Control antibodies or control antisera were prepared from pre-immune sera.
Plasmids
A murine gsc genomic clone (gsc74) which lacks TATA box was expressed using vector pcDNA3 (Invitrogen, Carlsbad, CA, USA). The pGEX-KG vector (Guan and Dixon, 1991) was used for expression of the GST-GSC fusion protein. SCL was isolated as described (Goldfarb et al., 1992) . Mouse Rb was supplied by Dr Robert Weinberg, Whitehead Institute (Bernards et al., 1989) .
Transfections
F5-5 cells were transfected by electroporation with pcDNA3-gsc74 DNA and selected in G418 (400 mg/ml) for 5 weeks. A representative clone, F5-5gsc74-3, was further transfected with either full length PU.1 cDNA/pCEP4 or with pCEP4 by electroporation. Electroporation was performed at 600 V, 25 mF using a Gene Pulser (BioRad, Richmond, CA, USA). Transfected cells were selected in the presence of either 200 mg/ml of G418 (Gibco ± BRL, Grand Island, NY, USA) or 400 U of hygromycin (Wako Pure Chemicals, Osaka, Japan).
Proteins produced by in vitro transcription and translation RNA was synthesized as described (Melton et al., 1984) . In vitro translation of RNA in rabbit reticulocyte lysates was conducted in the presence of [ 
Glutathion S-transferase (GST) fusion proteins
Bacterial expression of glutathione S-transferase (GST) fusion proteins including PU.1-N-terminal, SCL and GSCfull length employed the pGEX vector system as described (Guan and Dixon, 1991) . The plasmid pGEX-KG/PU.1-Nterminal was constructed using a 404 bp fragment encoding PU.1-N-terminal (amino acids 1 ± 132). These plasmids were expressed in BL21(DE3)pLysS cells.
His-tagged fusion proteins
Bacterial expression of a His-tag fusion protein including the C-terminal part of PU.1 (encoding amino acids 132 ± 272) was performed by the QIA express system (QIAGEN Inc., Chatsworth, CA, USA). Recombinant proteins were puri®ed by metal chelate anity chromatography over Ni-NTAagarose (QIAGEN Inc., Chatsworth, CA, USA).
Pulldown assay
In vitro translated protein in 1 ml of lysis buer (0.5% NP40, 50 mM Tris-HCl pH 8.0, 250 mM NaCl, 5 mM EDTA, 1 mM DTT, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 20 mM NaF, 20 mM b-glycerophosphate, 1 mM sodium orthovanadate, 1 mM benzamide) was precleared with GSTcontrol beads and incubated with either GST-N-terminal PU.1, GST C-terminal PU.1 beads or GST-GSC beads. In all experiments, 30 ml of 50% (v/v) beads were used per sample.
The beads were washed three times with 1 ml of high salt wash buer (250 mM NaCl, 0.5% NP40, 1 mM EDTA), twice with low salt buer (100 mM NaCl, 0.5% NP40, 1 mM EDTA), pelleted at 12 000 g for 10 s, and boiled in SDS ± PAGE sample buer. S-LABEL, ICN Pharmaceuticals, Inc., Irvine, CA, USA) in 3 ml of methionine-free medium for 2.5 h. Lysates were precleared with control antibodies and 30 ml of 50% (v/v) of A-Prep protein A beads for 1 h, and immunoprecipitated with 5 mg of anti-PU.1 antibodies followed by A-Prep protein A beads for 1 h. In the case of guinea-pig anti-GST-GSC serum, 30 ml of 50% (v/v) of protein G-Sepharose beads were used instead of A-Prep protein A beads. For releasing proteins from GST-GSC-agarose beads, samples were boiled in 2% SDS, 60 mM Tris, pH 8.0, 15 mM glutathione (Figure  3b,c) . For pull-down assay after immunoprecipitation, immunoprecipitates were boiled in 50 ml of 50 mM Tris, pH 7.4 buer containing 0.5% SDS, 1% NP40, 0.5% DOC and diluted with 1 ml lysis buer. For re-immunoprecipitation, the ®rst immunoprecipitates were boiled in 50 ml of 50 mM Tris, pH 7.4 buer containing 2% SDS and diluted with 1 ml lysis buer (Figure 7b ). Dried gels were analysed with an Image Analyser (Fuji, BAS-2000, Japan) .
Immunoprecipitation and re-immunoprecipitation assay
Western blot analysis F5-5 cells (1610 8 ) were lysed and pulled down with GST-GSC beads and separated on a 8 ± 16% SDS ± PAGE gel and transferred to an Immun-Blot PVDF membrane (Bio-Rad Lab., Hercules, CA, USA). Western blot was performed according to the manufacturer's protocol using Immun-Star (Bio-Rad Laboratory).
